Authors: Mary A. Williamson Mt(ascp) Phd,L. Michael Snyder Md
Acute and chronic renal failure (increased two to three times in 80% of patients and five times in 5% of patients)
Organ transplant (kidney, liver, heart), especially with complications (e.g., organ rejection, CMV infection, cyclosporin toxicity)
Alcoholism
DKA
After ERCP
Some cases of intracranial bleeding (unknown mechanism)
Macro forms in lymphoma, cirrhosis
Drugs
Induced acute pancreatitis (see preceding section on serum amylase)
Cholestatic effect (e.g., indomethacin)
Methodologic interference (e.g., pancreozymin [contains lipase], deoxycholate, glycocholate, taurocholate [prevent inactivation of enzyme], bilirubin [turbidimetric methods])
Chronic liver disease (e.g., cirrhosis) (usually ≤2 times normal)
Decreased In
Methodologic interference (e.g., presence of Hb, quinine, heavy metals, calcium ions)